Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Novel Antagonists for Low Molecular Weight Heparin and Heparin-Like Drugs.

Walter Jeske, Ph.D., Christine Schroeder, Margaret Prechel, Ph.D., Jeanine M. Walenga, PhD, Mamdouh Bakhos, M.D.

Blood (2009) 114 (22): 2092.

https://doi.org/10.1182/blood.V114.22.2092.2092

Published: 2009

Journal Articles

Functional Microparticles Are up Regulated in Patients with Anti-Heparin/Platelet Factor 4 Antibodies: A Potential Mechanism of Thrombogenesis in the Heparin-Induced Thrombocytopenia Syndrome.

Josephine Cunanan, MD, Michelle Kujawski, Ph.D., He Zhu, M.D., Margaret Prechel, Ph.D., Jeanine Walenga, Ph.D., Debra Hoppensteadt, Ph.D., Jawed Fareed, Ph.D.

Blood (2007) 110 (11): 2105.

https://doi.org/10.1182/blood.V110.11.2105.2105

Published: 2007

Journal Articles

Methodologic Variations in the Determinations of Anti-Platelet Factor 4-Heparin Antibodies in Patients Suspected of Having Heparin Induced Thrombocytopenia: Diagnostic and Prognostic Implications.

Jawed Fareed, PhD, Margaret Prechel, Ph.D., Michelle Kujawski, Ph.D., He Zhu, Ph.D., Jeanine Walenga, Ph.D., Debra Hoppensteadt, Ph.D., Josephine Cunanan, M.D., Renu Saxena, M.D.

Blood (2007) 110 (11): 3206.

https://doi.org/10.1182/blood.V110.11.3206.3206

Published: 2007

Journal Articles

A Unique Biomarker Is Associated with the Prevalence of Functional Heparin Induced Thrombocytopenia (HIT) Associated Antibodies: Results from Proteomic (ProteinChip Array) Profiling of ELISA Positive HIT Plasma Samples.

Michelle R. Kujawski, PhD, Margaret Prechel, Ph.D., He Zhu, M.D., Jeanine Walenga, Ph.D., Debra Hoppensteadt, Ph.D., Josephine Cunanan, M.D., Cafer Adiguzel, M.D., Jawed Fareed, Ph.D.

Blood (2007) 110 (11): 3205.

https://doi.org/10.1182/blood.V110.11.3205.3205

Published: 2007

Journal Articles

SRA Does Not Detect Potentially Relevant HIT Antibodies.

Margaret Prechel, Ph.D., Meredith K. McDonald, B.S., Walter P. Jeske, Ph.D., Amanda F. Drenth, B.S., Jeanine M. Walenga, Ph.D.

Blood (2004) 104 (11): 3028.

https://doi.org/10.1182/blood.V104.11.3028.3028

Published: 2004

NARROW

Novel Antagonists for Low Molecular Weight Heparin and Heparin-Like Drugs.

Functional Microparticles Are up Regulated in Patients with Anti-Heparin/Platelet Factor 4 Antibodies: A Potential Mechanism of Thrombogenesis in the Heparin-Induced Thrombocytopenia Syndrome.

Methodologic Variations in the Determinations of Anti-Platelet Factor 4-Heparin Antibodies in Patients Suspected of Having Heparin Induced Thrombocytopenia: Diagnostic and Prognostic Implications.

A Unique Biomarker Is Associated with the Prevalence of Functional Heparin Induced Thrombocytopenia (HIT) Associated Antibodies: Results from Proteomic (ProteinChip Array) Profiling of ELISA Positive HIT Plasma Samples.

SRA Does Not Detect Potentially Relevant HIT Antibodies.

Email alerts

ASH Publications

American Society of Hematology

Novel Antagonists for Low Molecular Weight Heparin and Heparin-Like Drugs.

Functional Microparticles Are up Regulated in Patients with Anti-Heparin/Platelet Factor 4 Antibodies: A Potential Mechanism of Thrombogenesis in the Heparin-Induced Thrombocytopenia Syndrome.

Methodologic Variations in the Determinations of Anti-Platelet Factor 4-Heparin Antibodies in Patients Suspected of Having Heparin Induced Thrombocytopenia: Diagnostic and Prognostic Implications.

A Unique Biomarker Is Associated with the Prevalence of Functional Heparin Induced Thrombocytopenia (HIT) Associated Antibodies: Results from Proteomic (ProteinChip Array) Profiling of ELISA Positive HIT Plasma Samples.

SRA Does Not Detect Potentially Relevant HIT Antibodies.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only